Fibrin‐specific poly(N‐isopropylacrylamide) nanogels for targeted delivery of tissue‐type plasminogen activator to treat thrombotic complications are well tolerated in vivo-Reference-Cited by-同舟云学术

Fibrin‐specific poly(N‐isopropylacrylamide) nanogels for targeted delivery of tissue‐type plasminogen activator to treat thrombotic complications are well tolerated in vivo

Published:2021-12-11 Issue: Volume: Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioeng Transl Med

Author:

Mihalko Emily P.¹²,Nellenbach Kimberly¹²,Krishnakumar Manasi¹,Moiseiwitsch Nina²,Sollinger Jennifer²,Cooley Brian C.³,Brown Ashley C.¹²^ORCID

Affiliation:

1. Joint Department of Biomedical Engineering of University of North Carolina Chapel Hill and North Carolina State University Raleigh North Carolina USA

2. Comparative Medicine Institute North Carolina State University Raleigh North Carolina USA

3. Department of Pathology and Laboratory Medicine University of North Carolina Chapel Hill North Carolina USA

Funder

American Heart Association

National Institutes of Health

North Carolina Biotechnology Center

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10277

Reference43 articles.

1. Molecular and Cellular Biology of Blood Coagulation

2. Remodeling the Blood Coagulation Cascade

3. How it all starts: Initiation of the clotting cascade

4. Bleeding and Coagulopathies in Critical Care

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clot-Targeted Nanogels for Dual-Delivery of AntithrombinIII and Tissue Plasminogen Activator to Mitigate Disseminated Intravascular Coagulation Complications;ACS Nano;2024-06-05

2. Biomaterials in Drug Delivery: Advancements in Cancer and Diverse Therapies—Review;International Journal of Molecular Sciences;2024-03-08

3. Biomaterials for treating sepsis-induced thromboinflammation;Frontiers in Biomaterials Science;2023-12-07

4. Engineered intravenous therapies for trauma;Current Opinion in Biomedical Engineering;2023-09

5. Recent Advances in Blood Cell-Inspired and Clot-Targeted Thrombolytic Therapies;Journal of Tissue Engineering and Regenerative Medicine;2023-02-17